Physician profile
Mridul Gupta
NPI 1760832687
$1,661.96
in general payments reported to CMS, 2019-2025
17 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $109 · 2021: $402 · 2022: $665 · 2023: $67.06 · 2024: $14.41 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216 · Travel and Lodging: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.30 |
| Travel and Lodging | $140.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $406.47 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.19 | 2019-2025 | |
| Abbvie INC. | $298.75 | 2021-2025 | |
| Pfizer INC. | $151.81 | 2021 | |
| Inari Medical, INC. | $151.47 | 2022 | |
| Mallinckrodt Enterprises LLC | $68.50 | 2019 | |
| Glaxosmithkline, LLC. | $47.04 | 2020-2021 | |
| Astellas Pharma US INC | $43.71 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $36.90 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $30.69 | 2022 | |
| Lilly USA, LLC | $24.94 | 2022-2023 | Jardiance |
| Vapotherm INC | $23.62 | 2022 | |
| United Therapeutics Corporation | $15.40 | 2019 | |
| Genzyme Corporation | $15.20 | 2022 | |
| La Jolla Pharmaceutical Company | $12.60 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tetraphase Pharmaceuticals, INC. | $12.09 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mridul Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.